Abstract:Sialic-acid-binding immunoglobulin-like lectins (Siglecs) are integral cell surface proteins crucial for the regulation of immune responses and the maintenance of immune tolerance through interactions with sialic acids. Siglecs recognize sialic acid moieties, usually found at the end of N-glycan and O-glycan chains. However, the different Siglecs prefer diverse presentations of the recognized sialic acid, depending on the type of glycosidic linkage used to link to the contiguous Gal/GalNAc or sialic acid moieties. This fact, together with possible O- or N-substitutions at the recognized glycan epitope significantly influences their roles in various immune-related processes1. Understanding the molecular details of Siglec-sialoglycan interactions is essential for unraveling their specificities and for the development of new molecules targeting these receptors. While traditional biophysical methods like isothermal titration calorimetry (ITC) have been utilized to measure binding between lectins and glycans, contemporary techniques such as surface plasmon resonance (SPR), microscale thermophoresis (MST), and biolayer interferometry (BLI) offer improved throughput. However, these methodologies require chemical modification and immobilization of at least one binding partner, which can interfere the recognition between the lectin and the ligand. Since siglecs display a large range of dissociation constants, depending on the (bio)chemical nature of the interacting partner, a general and robust method that could monitor and quantify binding would be highly welcomed. Herein, we propose the application of an NMR-based a competitive displacement assay, grounded on 19F T2-relaxation NMR and on the design, synthesis, and use of a strategic spy molecule, to assess and quantify sialoside ligand binding to Siglecs. We show that the use of this specific approach allows the quantification of Siglec binding for natural and modified sialosides, multivalent sialosides, and sialylated glycoproteins in solution, which differ in binding affinities in more than two orders of magnitude, thus providing invaluable insights into sialoglycan-mediated interactions.

ChemInform Abstract: Synthesis of 9-Substituted Sialic Acids as Probes for CD22-Ligand Interactions on B Cells

ChemInform Abstract: Chemoenzymatic Synthesis of Sialosides and Their Applications

Chemical and chemoenzymatic syntheses of sialyl Lewisa tetrasaccharide antigen

Total synthesis of a sialyl Lewis(x) derivative for the diagnosis of cancer.

Development of BODIPY labelled sialic acids as sialyltransferase substrates for direct detection of terminal galactose on N- and O-linked glycans

Synthesis and Biological Activities of Amino Acids Functionalized Α-Galcer Analogues.

Synthetic Sialosides Terminated with 8‐N‐Substituted Sialic Acid as Selective Substrates for Sialidases from Bacteria and Influenza Viruses

Direct Experimental Characterization of a Sialyl Cation

Chemoenzymatic Synthesis of Sulfated N-Glycans Recognized by Siglecs and Other Glycan-Binding Proteins

Synthesis Of Biologically Active N- And O-Linked Glycans With Multisialylated Poly-N-Acetyllactosamine Extensions Using P. Damsela Alpha 2-6 Sialyltransferase

Bioorthogonal Chemical Labeling Probes Targeting Sialic Acid Isomers for N-Glycan MALDI Imaging Mass Spectrometry of Tissues, Cells, and Biofluids

Transfer of synthetic sialic acid analogues to N- and O-linked glycoprotein glycans using four different mammalian sialyltransferases

Advances in the Biology and Chemistry of Sialic Acids

A versatile soluble siglec scaffold for sensitive and quantitative detection of glycan ligands

Quantifying Siglec-Sialylated Ligand Interactions: A versatile 19F-T2 CPMG Filtered Competitive NMR Displacement Assay

Structure–Activity Relationship of Metabolic Sialic Acid Inhibitors and Labeling Reagents

Amino Acids Bearing Aromatic or Heteroaromatic Substituents as a New Class of Ligands for the Lysosomal Sialic Acid Transporter Sialin

Recent Chemical Biology Approaches for Profiling Cell Surface Sialylation Status.

Engineering a Bacterial Sialyltransferase for Di-Sialylation of a Therapeutic Antibody

CD22 Ligands on a Natural N-Glycan Scaffold Efficiently Deliver Toxins to B-Lymphoma Cells.

Recent Approaches for Directly Profiling Cell Surface Sialoform.